Additional file 3 of HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results

Additional file 3 of HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results

Additional file 3. Figure S2. Treatment outcome based on HER2 copy number and HER2 IHC. (A) Progression-free survival in HER2 IHC 1+/2+ and (B) HER2 IHC 3+. (C) Overall survival in HER2 IHC 1+/2+ and (D) HER2 IHC 3+ (dichotomized by the respective median HER2 copy number)

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Seo, Jeongmin, Koh, Jiwon, Lee, Dae-Won, Kim, Jinyong, Ryu, Han Suk, Lee, Kyung-Hun, Kim, Tae-Yong, Im, Seock-Ah
Format: Bild
Sprache:eng
Schlagworte:
Cancer
Cell Biology
FOS: Biological sciences
Genetics
Medicine
Molecular Biology
Plant Biology
Science Policy
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Additional file 3. Figure S2. Treatment outcome based on HER2 copy number and HER2 IHC. (A) Progression-free survival in HER2 IHC 1+/2+ and (B) HER2 IHC 3+. (C) Overall survival in HER2 IHC 1+/2+ and (D) HER2 IHC 3+ (dichotomized by the respective median HER2 copy number)
DOI:10.6084/m9.figshare.26654245